Home › Cancro metastatico › Georgia
Studi clinici su Cancro metastatico nello stato di Georgia
34 studi su Cancro metastatico cercano partecipanti presso sedi nello stato di Georgia.
Città nello stato di Georgia
Testo ufficiale dello studio (inglese)
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Emory University, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06465069Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Piedmont Cancer Institute, Atlanta
- Piedmont Healthcare, Atlanta
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07562152A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Winship Cancer Institute of Emory University, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06270706A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Emory Winship Cancer Institute, Atlanta
- Augusta University, Augusta
In reclutamentoFase 1
Età 19 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06586957Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- University Cancer & Blood Center, LLC, Athens
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07222800A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Healthcare of Atlanta - Egleston Hospital, Atlanta
In reclutamentoFase 1/2
Fino a 25 anni · Tutti i sessi · Aggiornato il 25 set 2026 · NCT04094610A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- University Cancer & Blood Center, LLC, Athens
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06989437A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
- Emory Winship Cancer Institute, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 24 set 2026 · NCT07543055A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Piedmont Columbus Regional - John B. Amos Cancer Center, Columbus
- Central Georgia Cancer Care, Macon
- City of Hope National Medical Center, Atlanta Cancer Center, Newnan
- e altri 2
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07174336A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Emory University School of Medicine - Winship Cancer Institute, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07114601A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Winship Cancer Institute, Emory University, Atlanta
- Nancy N. & J.C. Lewis Cancer and Research Pavillion, Savannah
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07213804Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Tennessee Oncology, PLLC- Ringgold, Ringgold
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT07227415Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT04585958A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Marietta
In reclutamentoFase 3
Età da 18 a 130 · Tutti i sessi · Aggiornato il 8 set 2026 · NCT07647328A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University Cancer & Blood Center, LLC, Athens
- Emory University School of Medicine- Grady Campus, Atlanta
- Winship Cancer Institute, Emory University, Atlanta
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06119581AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Atlanta
In reclutamentoFase 1/2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 4 set 2026 · NCT07038343Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Winship Cancer Institute of Emory University, Atlanta
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT06072612A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Emory University School of Medicine, Atlanta
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 ago 2026 · NCT06769698FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Emory University Hospital, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT05614739A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
- Crinetics Study Site, Atlanta
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 31 lug 2026 · NCT07129252A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Winship Cancer Center - Emory University, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 lug 2026 · NCT06657144A Study of PYX-201 in Advanced Solid Tumors
- Winship Cancer Institute, Emory University, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 giu 2026 · NCT05720117A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Winship Cancer Institute, Emory University, Atlanta
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 27 mag 2026 · NCT05384626A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- Winship Cancer Institute at Emory University, Atlanta
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 mag 2026 · NCT07094204Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Piedmont Healthcare, Atlanta
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 mag 2026 · NCT05379985A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- Emory University, Atlanta
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 apr 2026 · NCT06064877A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Emory Winship Cancer Institute, Atlanta
In reclutamentoFase 2/3
Tutte le età · Tutti i sessi · Aggiornato il 2 apr 2026 · NCT06581406Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
- Emory Winship Cancer Institute, Atlanta
- Georgia Cancer Center at Augusta University, Augusta
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 apr 2026 · NCT05735080Venetoclax Basket Trial for High Risk Hematologic Malignancies
- Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
In reclutamentoFase 1
Età da 1 a 40 · Tutti i sessi · Aggiornato il 12 mar 2026 · NCT05292664Collection and Storage of Tissue and Blood Samples From Patients With Cancer
- Augusta University Medical Center, Augusta
In reclutamentoStudio osservazionale
2 Months · Tutti i sessi · Aggiornato il 5 mar 2026 · NCT02474160Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
- Emory Winship Cancer Institute, Atlanta
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 6 feb 2026 · NCT06127407SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Atlanta
- Massive Bio SYNERGY-AI site, Savannah
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 28 ott 2025 · NCT03452774Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases
- Emory University Hospital/Winship Cancer Institute, Atlanta
In reclutamentoFase 1 iniziale
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2025 · NCT06328686A Beta-only IL-2 ImmunoTherapY Study
- Emory - Winship Cancer Institute, Atlanta
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 lug 2025 · NCT05086692Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.